Black Elderberry Alcohol-Free

Black Elderberry Alcohol-Free

Herb Pharm4.8 (53 ratings)
Format:Liquid Quantity: 4 Fluid Ounce(s) · 168 servings
Goals
$44.78 $0.26 per serving

Product analysis

49 out of 100

Black Elderberry Alcohol-Free offers an alcohol-free elderberry preparation for people who prefer to avoid alcohol. Effects depend on the particular preparation, so routine immune benefits remain uncertain.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The elderberry form is not clearly disclosed, limiting quality comparisons. Its amount alone cannot establish equivalence to a particular standardized preparation.

Ingredient Transparency63

The listed amounts are stated, but ingredient forms are omitted. That makes comparisons between elderberry preparations less straightforward.

Value For Money40

Value cannot be judged reliably from the available information. The amount of elderberry alone does not establish how it compares with other preparations.

Customer Satisfaction72

Customer feedback is very positive, but based on few ratings. That leaves substantial uncertainty about wider buyer satisfaction.

Product Focus80

Elderberry gives the formula an immune-support focus. Evidence is mixed and depends on the specific preparation and regimen.

Format
Liquid
Container
4 Fluid Ounce(s)
Per serving
$0.26
Customer rating
4.8 · 53 ratings
Report analysis

Goals

Immunity
Impact
Highest effect
A+ Ingredient FitD PathwaysB+ EvidenceA+ Formulation Logic
European Elder · 828 mg

Elderberry has mixed, context-specific evidence from respiratory-illness and travel studies. The saved findings recognize the 828 mg serving, but that amount does not establish equivalence to a particular standardized extract or its regimen. An acute influenza trial was negative, and a different travel study did not significantly reduce cold incidence. These findings do not support a generic routine prevention or treatment claim.

How this product is rated for Immunity

Ingredient fit95

The selected serving makes a partial contribution against the comparison amounts, with differences between ingredients and any unresolved quantities retained.
Goal fit
The recognized ingredient roles are concentrated in the immunity goal; links to other goals also affect the saved finding.
Dose adequacy
The selected serving makes a partial contribution against the comparison amounts, with differences between ingredients and any unresolved quantities retained.

Pathways47

The most represented area is barrier and antimicrobial defense.
Depth
The most represented area is barrier and antimicrobial defense.
Breadth
The more substantially represented areas are barrier and antimicrobial defense.

Evidence80

European Elder supplies the strongest recognized basis here; the supplied context limits which clinical immune benefits can be claimed.
Evidence strength
European Elder supplies the strongest recognized basis here; the supplied context limits which clinical immune benefits can be claimed.
Studied preparation
The recognized preparations meet the saved check; this does not establish form superiority or automatic clinical benefit.

Formulation logic100

No defined ingredient-conflict condition was triggered by the supplied facts.
Partner coverage
The recognized ingredients can contribute independently or have required partners present; no additional combined benefit is established.
Conflicts
No defined ingredient-conflict condition was triggered by the supplied facts.
Effective doses
All recognized ingredients meet the minimum amount check; this is not a proven treatment threshold.
Study evidence

Ingredients

IngredientAmount per servingScore
Total Carbohydrates
1 Gram(s)
Black Elderberry fruit (Sambucus nigra) extract
828 mg 100
Gluten Free Adults 18–50 Organic
Report overview
A+ Composition And Label DisclosureA+ Composition And Label Disclosure
A serving provides 828 mg of Sambucus nigra fruit extract. The species and fruit are identified, making the botanical source clearer.
How this ingredient is rated

Composition and Label Disclosure100

The recorded preparation is Sambucus nigra fruit extract. The species and fruit are identified, making the botanical source clearer.
Botanical Identity Detail
The ingredient is identified as Sambucus nigra fruit extract. The species and fruit are identified, making the botanical source clearer.

Composition and Label Disclosure100

The saved information specifies 828 mg of the preparation per serving.
Actual Preparation Amount Disclosure
The actual preparation amount is recorded as 828 mg per serving.

Commercial Price and Usability

No ingredient-specific value comparison was evaluated.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Elderberry for prevention and treatment of viral respiratory illnesses: a systematic review.
    Wieland LS; Piechotta V; Feinberg T; Ludeman E; Hutton B; Kanji S; Seely D; Garritty C · BMC complementary medicine and therapies · 2021
    Systematic review5 studies pooledImmunity forEuropean Elder
  2. Select Dietary Supplement Ingredients for Preserving and Protecting the Immune System in Healthy Individuals: A Systematic Review.
    Crawford C; Brown LL; Costello RB; Deuster PA · Nutrients · 2022
    Systematic review39 studies pooledImmunity forEuropean Elder
  3. Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials
    Jessie Hawkins, Christy Baker, Lindsey Cherry, Erich Dunne · Complementary Therapies in Medicine · 2019
    Meta-analysis180 participants4 studies pooledImmunity forEuropean Elder
  4. Elderberry Supplementation Reduces Cold Duration and Symptoms in Air-Travellers: A Randomized, Double-Blind Placebo-Controlled Clinical Trial.
    Tiralongo E; Wee SS; Lea RA · Nutrients · 2016
    Randomized trial312 participantsImmunity forEuropean Elder
  5. Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections
    Z Zakay-Rones, E Thom, T Wollan, J Wadstein · Journal of International Medical Research · 2004
    Randomized trial60 participantsImmunity forEuropean Elder